Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Woolley

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1978
Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasmJ S Macdonald, M E Lippman, P V Woolley, et al.
Cancer|August 1, 1976
Extranodal presentation of non-Hodgkin's lymphomas in the testisP V Woolley, C K Osborne, J A Levi, et al.
British Journal of Haematology|August 1, 1983
Methotrexate-induced immune haemolytic anaemiaP V Woolley, R A Sacher, V M Priego, et al.
Investigational New Drugs|January 1, 1984
A Phase I trial of spirogermanium administered on a continuous infusion scheduleP V Woolley, J D Ahlgren, P J Byrne, et al.
Cancer|July 1, 1979
5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancerJ S MacDonald, P V Woolley, T Smythe, et al.
Cancer Treatment Reports|November 11, 1976
5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FUJ S Macdonald, D F Kisner, T Smythe, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1981
Fast neutron irradiation for locally advanced pancreatic cancerF P Smith, P S Schein, J S Macdonald, et al.
Investigational New Drugs|September 1, 1988
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapyM McCabe, F P Smith, J S Macdonald, et al.
Cancer|February 1, 1978
Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancerR G Wiggans, P V Woolley, J S Macdonald, et al.
Cancer Research|October 1, 1981
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosoureaP V Woolley, P V Luc, A Rahman, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|January 1, 1978
Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasmJ S Macdonald, M E Lippman, P V Woolley, et al.
Cancer|August 1, 1976
Extranodal presentation of non-Hodgkin's lymphomas in the testisP V Woolley, C K Osborne, J A Levi, et al.
British Journal of Haematology|August 1, 1983
Methotrexate-induced immune haemolytic anaemiaP V Woolley, R A Sacher, V M Priego, et al.
Investigational New Drugs|January 1, 1984
A Phase I trial of spirogermanium administered on a continuous infusion scheduleP V Woolley, J D Ahlgren, P J Byrne, et al.
Cancer|July 1, 1979
5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancerJ S MacDonald, P V Woolley, T Smythe, et al.
Cancer Treatment Reports|November 11, 1976
5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FUJ S Macdonald, D F Kisner, T Smythe, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1981
Fast neutron irradiation for locally advanced pancreatic cancerF P Smith, P S Schein, J S Macdonald, et al.
Investigational New Drugs|September 1, 1988
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapyM McCabe, F P Smith, J S Macdonald, et al.
Cancer|February 1, 1978
Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancerR G Wiggans, P V Woolley, J S Macdonald, et al.
Cancer Research|October 1, 1981
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosoureaP V Woolley, P V Luc, A Rahman, et al.
Pageof 10